https://www.healio.com/news/endocrinology/20221228/semaglutide-tirzepatide-trial-data-top-2022-obesity-news
0
0
12/30/22 at 1:41pm
Organization
Healio
Authors
Healio and Endocrine Today editors have compiled the top obesity news from 2022. Readers were most interested in the latest trial data on anti-obesity medications, such as semaglutide (Wegovy, Novo Nordisk) and tirzepatide (Mounjaro, Eli Lilly), benefits stem…
Create an account
or login to join the discussion